ロード中...
Targeting Activated Synovial Fibroblasts in Rheumatoid Arthritis by Peficitinib
Background: Synovial fibroblasts (SF) play a major role in the pathogenesis of rheumatoid arthritis (RA) and develop an aggressive phenotype destroying cartilage and bone, thus termed RASF. JAK inhibitors have shown to be an efficient therapeutic option in RA treatment, but less is known about the e...
保存先:
| 出版年: | Front Immunol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6448044/ https://ncbi.nlm.nih.gov/pubmed/30984167 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.00541 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|